Sudhir Manne - Krebs Biochemicals Head Nellore
| KREBSBIO | 74.60 1.40 1.84% |
Executive
Sudhir Manne is Head Nellore of Krebs Biochemicals and
| Address | Kothapalli Village, Visakhapatnam, India, 531031 |
| Phone | 91 91 2114 4984 |
| Web | https://krebsbiochem.com |
Krebs Biochemicals Management Efficiency
The company has return on total asset (ROA) of (0.0532) % which means that it has lost $0.0532 on every $100 spent on assets. This is way below average. Krebs Biochemicals' management efficiency ratios could be used to measure how well Krebs Biochemicals manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Krebs Biochemicals' Other Current Assets are increasing as compared to previous years. The Krebs Biochemicals' current Total Current Assets is estimated to increase to about 278.7 M, while Total Assets are projected to decrease to under 1.3 B.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Robin Sullivan | ROUTE MOBILE LIMITED | N/A | |
| Sudhir Kumar | V2 Retail Limited | N/A | |
| Sundar | Styrenix Performance Materials | 75 | |
| Navin Bhandaradamane | Tree House Education | ||
| Gautam Badalia | ROUTE MOBILE LIMITED | N/A | |
| N Gupta | Paramount Communications Limite | N/A | |
| Rajeshwar Gill | ROUTE MOBILE LIMITED | N/A | |
| R Marwah | Paramount Communications Limite | N/A | |
| Paresh Jain | Shaily Engineering Plastics | N/A | |
| Sammy Mamdani | ROUTE MOBILE LIMITED | N/A | |
| Pravesh Srivastava | Hexa Tradex Limited | N/A | |
| Dimple Mehta | Shaily Engineering Plastics | N/A | |
| Shakti Mohanty | V2 Retail Limited | N/A | |
| Manshu Tandon | V2 Retail Limited | N/A | |
| Rainer Viertel | ROUTE MOBILE LIMITED | N/A | |
| Shambhu Agarwal | Paramount Communications Limite | N/A | |
| Pratik Adukia | V2 Retail Limited | N/A | |
| Ritesh Kumar | V2 Retail Limited | N/A | |
| Abhishek Khemka | V2 Retail Limited | N/A | |
| Kamal Thakur | ROUTE MOBILE LIMITED | N/A | |
| Surinder Kumar | V2 Retail Limited | N/A | |
Management Performance
| Return On Asset | -0.0532 |
Krebs Biochemicals and Leadership Team
Elected by the shareholders, the Krebs Biochemicals' board of directors comprises two types of representatives: Krebs Biochemicals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Krebs. The board's role is to monitor Krebs Biochemicals' management team and ensure that shareholders' interests are well served. Krebs Biochemicals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Krebs Biochemicals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Rakesh Kalbate, Company Officer | ||
| Aditya Ravi, Head Vizag | ||
| Sudhir Manne, Head Nellore | ||
| Keyur Doshi, Company Officer | ||
| Ritesh Jain, Chief Officer | ||
| Ravi Babu, Chief Officer | ||
| Jitendra Shah, CEO MD | ||
| Pabitra Bhattacharya, MD Director |
Krebs Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Krebs Biochemicals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.0532 | ||||
| Profit Margin | (0.50) % | ||||
| Operating Margin | (0.54) % | ||||
| Current Valuation | 3.61 B | ||||
| Shares Outstanding | 21.56 M | ||||
| Shares Owned By Insiders | 77.55 % | ||||
| Price To Sales | 3.34 X | ||||
| Revenue | 504.21 M | ||||
| Gross Profit | 384.93 M | ||||
| EBITDA | (82.73 M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Other Information on Investing in Krebs Stock
Krebs Biochemicals financial ratios help investors to determine whether Krebs Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Krebs with respect to the benefits of owning Krebs Biochemicals security.